Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
Taiwan · Delayed Price · Currency is TWD 29.45
+0.40 (1.38%)
At close: May 8, 2026
Genomics BioSci & Tech. Market Cap
Genomics BioSci & Tech. has a market cap or net worth of 2.13 billion as of May 8, 2026. Its market cap has increased by 78.48% in one year.
Market Cap
2.13B
Enterprise Value
2.66B
Revenue
708.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.45
Market Cap Chart
Since December 16, 2013, Genomics BioSci & Tech.'s market cap has increased from 1.58B to 2.13B, an increase of 34.94%. That is a compound annual growth rate of 2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 2.13B | 14.59% |
| Dec 31, 2025 | 1.86B | 33.85% |
| Dec 31, 2024 | 1.39B | -7.69% |
| Dec 29, 2023 | 1.51B | 19.84% |
| Dec 30, 2022 | 1.26B | 11.67% |
| Dec 30, 2021 | 1.13B | 0.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 17.55B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.47B |
| Uwell Biopharma | 8.20B |
| Intelligene | 7.40B |
| Obigen Pharma | 3.99B |
| BIONET Therapeutics | 2.81B |
| Pet Pharm Biotech | 2.73B |
| FullHope Biomedical | 1.12B |